A detailed history of Comerica Bank transactions in Geron Corp stock. As of the latest transaction made, Comerica Bank holds 2,755 shares of GERN stock, worth $7,906. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,755
Holding current value
$7,906
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.17 - $4.99 $11,488 - $13,747
2,755 New
2,755 $12,000
Q3 2023

Nov 21, 2023

BUY
$2.11 - $3.28 $21,100 - $32,800
10,000 New
10,000 $21,000
Q1 2021

Apr 28, 2021

SELL
$1.52 - $2.1 $15,835 - $21,877
-10,418 Closed
0 $0
Q3 2020

Oct 30, 2020

BUY
$1.59 - $2.19 $16,564 - $22,815
10,418 New
10,418 $18,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.08B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.